The current analysis has shown that the rate (both per-injection and per-patient), outcome and presentation of PDSS events being reported during routine clinical use of olanzapine LAI are similar to those reported in clinical trials.
Currently, tumor grade is the best predictor of outcome at first presentation of noninvasive papillary (Ta) bladder cancer.
It seemed, for a successful project outcome, that the presentation of the data was more important than its objective scientific certainty.
We anticipated too much diversity among the studies with regard to the participants (diversity of fractures), interventions (duration, frequency, and setting), and outcome (diversity and presentation of results) to make an appropriate quantitative analysis (meta-analysis).
To assess the validity of each study, we evaluated the similarity of groups at the baseline, the description of primary and secondary outcomes and the presentation of the results.
Peacock et al. developed a distributional approach to the dichotomisation of normally distributed outcomes allowing the presentation of a comparison of proportions with a measure of precision which reflects the comparison of means.
We used the WHO Global Survey dataset to determine the risk of adverse maternal/perinatal outcomes associated with presentation of the second twin, following vaginal delivery of a vertex first twin.
Risks of maternal and perinatal outcomes associated with presentation of the second twin were determined using generalized linear mixed models (GENLINMIXED) with facility and country as random effects, to account for clustering of individuals within facilities and facilities within countries.
The guidelines for assessing and improving the methodological quality of economic evaluations in newborn screening are organized into 11 categories: "bibliographic details", "study question and design", "modelling", "health outcomes", "costs", "discounting", "presentation of results", "sensitivity analyses", "discussion", "conclusions", and "commentary".
The main reasons for exclusion at this stage were lack of a pain outcome separate from an overall outcome score or the presentation of results as means only.
